| Genomic DNA from tissue and cells |
|
Format |
Sample size
|
Typical yield
|
Product
|
|
Single prep (silica-membrane technology) |
|
|
|
|
|
|
|
Mini spin columns |
25 mg,
102–107 cells
|
20–35 µg
|
NucleoSpin® Tissue |
|
|
|
|
XS spin columns
|
0.0025–10 mg,
10-104 cells
|
0.1 ng–3 µg
|
NucleoSpin® Tissue XS |
|
|
|
|
|
|
Gravity flow columns
(anion-exchange
chromatography) |
20–400 mg
|
20–500 µg
|
NucleoBond® AXG |
|
Manual and automated high throughput (HTP) |
|
|
|
|
|
|
|
8-well strips
(silica-membrane technology) |
< 20 mg,
< 106 cells
|
15–25 µg/well
|
NucleoSpin® 8 Tissue
NucleoSpin® 8 Tissue Core Kit |
|
|
|
|
|
|
|
|
|
|
96-well plates
(silica-membrane technology) |
< 20 mg,
< 106 cells
|
15–25 µg/well
|
NucleoSpin® 96 Tissue
NucleoSpin® 96 Tissue Core Kit |
|
|
|
|
|
|
|
|
96-well systems
(magnetic-bead technology) |
< 20 mg/well
107 cells/well
|
10–20 µg/well
|
NucleoMag® 96 Tissue |
|
|
|
|
|
| Genomic DNA from FFPE samples |
|
Format |
Sample size
|
Typical yield
|
Product |
|
Single prep (silica-membrane technology) |
|
|
|
|
Mini spin column – XS design |
≤ 7 sections (10 µm) of 250 mm2 total area (<15 mg paraffin)
|
Depending on amount and quality of the sample
|
NucleosSpin® FFPE DNA |